Transitioning from epicutaneous to oral peanut immunotherapy

INTRODUCTION: Epicutaneous immunotherapy (EPIT) has been tested in clinical trials for children with peanut allergy (PA) for its safety and efficacy in inducing desensitization. Aside from peanut avoidance and symptom management, oral immunotherapy (OIT) is another option for PA patients. However, O...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Lauren, Kost, Laurie, Anderson, Brent, Long, Andrew, Sindher, Sayantani B., Chinthrajah, R. Sharon, Collins, William J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Allergy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939758/
https://www.ncbi.nlm.nih.gov/pubmed/36814725
http://dx.doi.org/10.3389/falgy.2023.1089308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939758/
https://www.ncbi.nlm.nih.gov/pubmed/36814725
http://dx.doi.org/10.3389/falgy.2023.1089308

Ejemplares similares